Polyendocrine metabolic ovarian syndrome (PMOS) putting half a million Aussies at quadruple risk of heart disease
Australian researchers are highlighting a study showing that women with polyendocrine metabolic ovarian syndrome (PMOS) have a four times higher risk of heart disease. The report urges Australian women to seek early screening and adopt preventative lifestyle measures.
Why it matters
It provides actionable health advice for a specific population segment, emphasizing the importance of early diagnosis for a common, incurable condition.
- 12.23am . First published July 20, 2026 - 10.30pm
Share article An estimated half a million women in Australia are at higher risk of heart disease due to an incurable hormone condition .
Research has revealed polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS), could significantly increase a woman’s risk of developing heart disease.
Half a million Australian women may be four times more likely to develop heart disease, according to new research. Chris Hopkins
A team of researchers in the US analysed health insurance data from more than 413,000 women with PMOS aged between 18 and 50.
They discovered those with the condition were four times more likely to develop heart disease compared to women without PMOS.
The risk remained even after accounting for other factors that may lead to heart disease, including obesity, high blood pressure, high cholesterol, and diabetes.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in